Fluoxetine: Sensitive Ages and Genotypes for Adverse Effects in Juvenile Monkeys
氟西汀:对幼猴产生不良影响的敏感年龄和基因型
基本信息
- 批准号:8530647
- 负责人:
- 金额:$ 13.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-04-01 至 2016-03-31
- 项目状态:已结题
- 来源:
- 关键词:12 year old3 year old4 year oldAddressAdolescentAdverse effectsAffectAffectiveAgeAnimal ModelAnimalsAreaAttentionAutopsyBasic ScienceBehaviorBehavior DisordersBehavioralBehavioral SymptomsBenefits and RisksBrainCerebrospinal FluidChildChildhoodClinical ResearchCognitiveCommunitiesComputersControl GroupsDendritic SpinesDesire for foodDevelopmentDiseaseDoseDrug KineticsDrug usageEmotionalEquilibriumFluoxetineGenesGeneticGenetic PolymorphismGenetic ScreeningGenotypeGoalsGrowthHippocampus (Brain)HumanKnowledgeLiteratureLong-Term EffectsLongitudinal StudiesMacaca mulattaMethodsModelingMonitorMonkeysMonoamine Oxidase AOralPharmaceutical PreparationsPharmacodynamicsPharmacotherapyPlacebosPlasmaPopulationPrefrontal CortexPrimatesPsychotropic DrugsPubertyRegulationRewardsRodentRoleSelective Serotonin Reuptake InhibitorSerotoninShort-Term MemorySignal TransductionSleepStagingStructureSubgroupSynapsesSystemTestingTherapeuticToxic effectVertebral columnWalkersbasebehavior testbrain morphologychild depressioncognitive functiondentate gyrusexecutive functionexperienceindexinginfancyjuvenile animalmonoaminenonhuman primatepublic health relevanceresponseselective attentionsocialtouchscreen
项目摘要
DESCRIPTION (provided by applicant): The biomedical literature has documented increasing use of psychoactive drugs in childhood behavior disorders and there is public concern over this issue. This application uses the rhesus monkey (1 to 4 years of age) as a juvenile animal model to: 1. test the hypothesis that the serotonin reuptake inhibitor fluoxetine influences activity and affective behavior during dosing at the juvenile stage of brain development. Information to identify a fluoxetine dose similar to human therapy will be provided by an initial pharmacokinetic study of plasma fluoxetine/norfluoxetine with a pharmacodynamics component to quantify serotonin in cerebrospinal fluid, a sensitive index in previous human and nonhuman primate studies. The affective behavior tests include some used in children (reward delay) as well as behaviors regulated by the serotonin system in monkeys (social intruder). Activity monitoring will conducted with actimeters. 2. identify alterations in brain morphology that could signal interference with normal juvenile brain development, specifically the proliferation and pruning of dendritic spine synapses. Daily oral fluoxetine will be given from 1 to 3 years of age (approximately 4 to 12 years of age in children). A placebo will be administered exclusively to a separate control group. Potential long-term effects will be assessed in all monkeys after discontinuation of dosing using an automated cognitive test battery. Dendritic spine synapse numbers in hippocampus (CA1, CA3, dentate gyrus) and prefrontal cortex (Walker area 46) will be studied at 4 years of age, one year after termination of dosing. This assessment is relevant to one of the most important components of childhood brain development, synaptic pruning. 3. determine whether some children may be more sensitive to these changes than others based on their genetic makeup. Colony-wide genetic screening at our primate center (CNPRC) allows selection of subgroups of monkeys with low and high activity MAOA gene polymorphisms. MAOA metabolizes serotonin, as well as other monoamines, and human populations have a similar distribution of low and high activity polymorphisms. Findings from this study, integrated with clinical studies and experience, can help guide safe use of fluoxetine in children.
PUBLIC HEALTH RELEVANCE: This project studies fluoxetine, a drug approved for use in children for depression and obsessive-compulsive disease, in a juvenile animal model. We will determine whether fluoxetine changes affective (emotional) behavior and late childhood brain development, and determine whether some children may be more sensitive than others based on their genetic makeup. This study will help guide safe use of fluoxetine in children.
描述(申请人提供):生物医学文献记录了越来越多的精神活性药物在儿童行为障碍中的使用,这一问题引起了公众的关注。本应用使用恒河猴(1至4岁)作为幼年动物模型:1.验证5-羟色胺重摄取抑制剂氟西汀在大脑发育幼年阶段给药影响活动和情感行为的假设。确定类似于人类治疗的氟西汀剂量的信息将通过对血浆氟西汀/去氟西汀进行的初步药代动力学研究提供,该研究带有药效学成分,以量化脑脊液中的5-羟色胺,这是以前人类和非人类灵长类动物研究中的一个敏感指标。情感行为测试包括一些用于儿童的测试(奖赏延迟),以及猴子受5-羟色胺系统调节的行为(社交入侵者)。活动监测将使用活动计进行。2.识别大脑形态的变化,这些变化可能会干扰正常的青少年大脑发育,特别是树突突触的增殖和修剪。每天口服氟西汀的年龄为1至3岁(儿童约为4至12岁)。安慰剂将专门用于单独的对照组。在停止使用自动认知测试电池给药后,将对所有猴子的潜在长期影响进行评估。停止给药一年后,将在4岁时研究海马(CA1、CA3、齿状回)和前额叶皮质(Walker区46区)中树突棘突触的数量。这项评估与儿童大脑发育最重要的组成部分之一--突触修剪有关。3.根据孩子的基因组成,确定他们是否比其他孩子对这些变化更敏感。在我们的灵长类中心(CNPRC)进行的群体范围的遗传筛选可以选择MAOA基因低活性和高活性的猴子亚群。MAOA代谢5-羟色胺和其他单胺,人类群体具有相似的低活性和高活性多态分布。这项研究的发现,结合临床研究和经验,可以帮助指导儿童安全使用氟西汀。
公共卫生相关性:该项目在青少年动物模型中研究氟西汀,这是一种被批准用于儿童抑郁症和强迫症的药物。我们将确定氟西汀是否会改变情感(情绪)行为和儿童后期大脑发育,并根据儿童的基因构成确定一些儿童是否比其他儿童更敏感。这项研究将有助于指导儿童安全使用氟西汀。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARI S GOLUB其他文献
MARI S GOLUB的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARI S GOLUB', 18)}}的其他基金
Fluoxetine: Sensitive Ages and Genotypes for Adverse Effects in Juvenile Monkeys
氟西汀:对幼猴产生不良影响的敏感年龄和基因型
- 批准号:
8448618 - 财政年份:2011
- 资助金额:
$ 13.3万 - 项目类别:
Fluoxetine: Sensitive Ages and Genotypes for Adverse Effects in Juvenile Monkeys
氟西汀:对幼猴产生不良影响的敏感年龄和基因型
- 批准号:
8828261 - 财政年份:2011
- 资助金额:
$ 13.3万 - 项目类别:
Fluoxetine: Sensitive Ages and Genotypes for Adverse Effects in Juvenile Monkeys
氟西汀:对幼猴产生不良影响的敏感年龄和基因型
- 批准号:
8107413 - 财政年份:2011
- 资助金额:
$ 13.3万 - 项目类别:
Fluoxetine: Sensitive Ages and Genotypes for Adverse Effects in Juvenile Monkeys
氟西汀:对幼猴产生不良影响的敏感年龄和基因型
- 批准号:
8249823 - 财政年份:2011
- 资助金额:
$ 13.3万 - 项目类别:
Fluoxetine: Sensitive Ages and Genotypes for Adverse Effects in Juvenile Monkeys
氟西汀:对幼猴产生不良影响的敏感年龄和基因型
- 批准号:
8651928 - 财政年份:2011
- 资助金额:
$ 13.3万 - 项目类别:
相似海外基金
Development and social implementation of unified developmental screening for health checkups for 3-year-old children in local governments
地方政府统一开展3岁儿童健康检查发育筛查工作的开展及社会实施
- 批准号:
23H01039 - 财政年份:2023
- 资助金额:
$ 13.3万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Low vision screening at 3-year-old children's health check-ups: development of a simple and accurate visual acuity testing software
3岁儿童体检中的低视力筛查:开发简单准确的视力测试软件
- 批准号:
23K02283 - 财政年份:2023
- 资助金额:
$ 13.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
0-3-year-old children's language and literacy learning at home in a digital age (0-3s, Tech and Talk)
数字时代0-3岁儿童在家学习语言和识字(0-3s,Tech and Talk)
- 批准号:
ES/W001020/1 - 财政年份:2022
- 资助金额:
$ 13.3万 - 项目类别:
Research Grant
Associations between physical activity levels of mothers and their 1-3 year old children: examining maternal self-efficacy as a mediator
母亲和 1-3 岁孩子体力活动水平之间的关联:检查作为中介的母亲自我效能感
- 批准号:
324339 - 财政年份:2015
- 资助金额:
$ 13.3万 - 项目类别:
Lived time of 3-year-old children in early childhood education and care: Reconsidering continuity of life and development
3岁儿童在幼儿教育和保育中的生存时间:重新思考生命和发展的连续性
- 批准号:
15K17356 - 财政年份:2015
- 资助金额:
$ 13.3万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Development of family support program to form healthy 3-year-old children and their mothers
制定家庭支持计划,培养健康的3岁儿童及其母亲
- 批准号:
24593457 - 财政年份:2012
- 资助金额:
$ 13.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
SUPPORTING 2 AND 3 YEAR OLD PRE-KINDERGARTEN READINESS
支持 2 岁和 3 岁儿童做好学前准备
- 批准号:
7699693 - 财政年份:2008
- 资助金额:
$ 13.3万 - 项目类别:
ADENOIDECTOMY FOR OTITIS MEDIA IN 2/3 YEAR OLD CHILDREN
2/3 岁儿童中耳炎的腺切除术
- 批准号:
6350559 - 财政年份:1997
- 资助金额:
$ 13.3万 - 项目类别:
EMOTIONAL AND BEHAVIOR PROBLEMS IN 1-3 YEAR OLD CHILDREN
1-3 岁儿童的情绪和行为问题
- 批准号:
2890762 - 财政年份:1997
- 资助金额:
$ 13.3万 - 项目类别:
EMOTIONAL AND BEHAVIOR PROBLEMS IN 1-3 YEAR OLD CHILDREN
1-3 岁儿童的情绪和行为问题
- 批准号:
2841735 - 财政年份:1997
- 资助金额:
$ 13.3万 - 项目类别: